|
| Brand Name: | Lingyao |
| Model Number: | LYAPL1-20 |
| MOQ: | 1 unit |
| Price: | 50,000-500,000 USD/unit |
| Payment Terms: | T/T |
| Supply Ability: | 1-10 units per month |
Revolutionize Pharmaceutical Production with Next-Gen Ampoule Filling and Sealing Technology
In the fast-paced world of pharmaceutical manufacturing, efficiency and precision are non-negotiable. Our High-Speed Precision Ampoule Filling Line is engineered to meet the rigorous demands of vaccine production, sterile injectables, and critical biologics. Designed for versatility across 1-20ml ampoules, this cutting-edge system integrates automated filling, laser sealing, and real-time quality control to deliver unmatched accuracy (±0.5% dosage deviation) and throughput up to 36,000 ampoules/hour—ideal for both large-scale vaccine campaigns and niche biologic therapies.
Why Choose Our Ampoule Filling Line?
| Sealing Gas | Gas (liquefied Gas)+ Oxygen,oxyhydrogen Generation Gas, Natural Gas |
| Application | Liquid Medicine Filling For Ampoules |
| Breakage Rate | <1%(whole Line) |
| Standard | GMP |
| Function | Water Flushing, Air Flushing, Drying And Sterilization, Cooling, Filling, Sealing |
| Capacity | 15,000-36,000 Ampoules/hour(depends On Ampoule Size) |
| Fresh Water Consumption and Pressure | 0.2-0.4Mpa/0.6-1.0 Cbm/h |
| Clarity | 99% |
| Control System | Advanced Intelligent Electronic Control Technology |
| Sterilization Oven Type | Tunnel Type Hot Air Circulation Sterilization Oven |
Applications That Save Lives
From pandemic-ready vaccine production to life-saving antivenoms and monoclonal antibodies, this ampoule line supports lyophilized powders, liquids, and suspensions. Its modular design allows rapid changeovers between 1ml single-dose COVID boosters and 20ml antidiabetic injectables, minimizing downtime.
Global Trust, Local Support
Trusted by pharmaceutical giants in Russia, India, and the Middle East, we offer 24/7 remote diagnostics and on-site training. Elevate your production with a machine that combines German engineering precision and cost-effective Chinese manufacturing—where quality meets affordability.
Act Now: Limited slots available for Q4 2025 installations. Request a live demo and see how 10+ pharma labs achieved 40% faster time-to-market!
